[18F]FAPI-74 serving as complementary diagnostic in Avacta Phase 1 trial

May 23, 2024 – SOFIE is pleased to partner with Avacta through Avacta’s use […]

2025-10-15T16:42:11+00:0023, May 2024|News|

[68Ga]Ga-FAPI-46 PET/CT for penile cancer – a feasibility study

Lennert Eismann, Stephan T Ledderose, Benazir Enzinger, Elena Berg, Thilo Westhofen, Severin Rodler, Gerald B […]

2025-10-15T16:40:44+00:0018, May 2024|Publications|

68Ga-Fibroblast Activation Protein Inhibitor PET/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical Therapy

Helena Lanzafame, Ilektra A Mavroeidi, Kim M Pabst, Mélanie Desaulniers, Marc Ingenwerth, Nader Hirmas, Lukas […]

2025-10-15T16:40:44+00:009, May 2024|Publications|

A Systematic Review on the Diagnostic Value of Fibroblast Activation Protein Inhibitor PET/CT in Genitourinary Cancers

Marinus J Hagens, Pim J van Leeuwen, Maurits Wondergem, Thierry N Boellaard, Francesco Sanguedolce, Daniela […]

2025-10-15T16:39:32+00:0018, Apr 2024|Publications|

Highlights of the 36th EANM Annual Congress 2023, from hometown Vienna, Austria: “A SYMPHONY OF SCIENCE”

David Kersting, Silvia Morbelli, Sophie E. M. Veldhuijzen van Zanten & Hein J. Verberne

2025-10-15T16:39:32+00:004, Apr 2024|Publications|

Advancements in Diagnostics

Presented by: Sherly Mosessian, PhD, SOFIE Chief Scientific Officer
7th Theranostics World Congress – Santiago, Chile
March […]

2025-11-03T16:05:44+00:0023, Mar 2024|Presentations|

Focus on FAPI Newsletter – Q4 2024

A WORD FROM OUR CHIEF SCIENTIFIC OFFICER

Dear FAPI Community,

We are looking forward to a […]

2025-12-03T20:08:45+00:0012, Mar 2024|Newsletter|

Fibroblast Activation Protein α-Directed Imaging and Therapy of Solitary Fibrous Tumor

Rainer Hamacher, Kim M Pabst, Phyllis F Cheung, Christoph E Heilig, Jennifer Hüllein, Sven-Thorsten Liffers, […]

2025-10-15T16:39:32+00:0018, Feb 2024|Publications|

18F-FAPI-04 Outperforms 18F-FDG PET/CT in Clinical Assessments of Patients with Pancreatic Adenocarcinoma

Xiang Li, Na Lu, Lili Lin, Yiwen Chen, Shuye Yang, Huatao Wang, Xinyuan Liu, Chengyi […]

2025-10-15T16:39:29+00:0012, Feb 2024|Publications|

Focus on FAPI Newsletter – Q2 2023

A WORD FROM OUR CHIEF SCIENTIFIC OFFICER

2025-12-03T20:05:53+00:006, Dec 2023|Newsletter|
Go to Top